Enhertu® (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate indicated for the treatment of various types of cancer including gastric, breast and non-small …
ZENBEXUS™ (iberdomide), used in combination with daratumumab and hyaluronidase-fihj plus dexamethasone (ZDd), is indicated for the treatment of adult patients …
XOLREMDI™ (mavorixafor) is a first-in-class, oral therapy indicated for the treatment of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, a …
REVTORPYK (gedatolisib) is indicated for use in combination with fulvestrant, with or without palbociclib, for adult patients with hormone receptor …
Truqap® (capivasertib), in combination with Faslodex® (fulvestrant), is a novel therapeutic option for the treatment of hormone receptor (HR)-positive, HER2-negative …
XOCOVA® (ensitrelvir) is authorised for the treatment of post-exposure prophylaxis (PEP) of coronavirus disease 2019 (Covid‑19) in adults and adolescents …
SPINRAZA (nusinersen) is indicated for the treatment of spinal muscular atrophy (SMA) in paediatric and adult patients. It was originally developed …
ELAHERE® (mirvetuximab soravtansine) is a novel antibody-drug conjugate (ADC) indicated for the treatment of adult patients with folate receptor alpha …
Idvynso™ (doravirine/islatravir) is a two‑drug, single‑tablet regimen containing doravirine and islatravir, authorised for the treatment of human immunodeficiency virus (HIV)‑1 …
Tezspire (tezepelumab-ekko) is a first-in-class human monoclonal antibody indicated for add-on maintenance treatment of severe asthma in adults and children …
Lipaglyn™ (saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridaemia in Type 2 diabetes …
Lifyorli™ (relacorilant) is a selective glucocorticoid receptor antagonist (SGRA), which, along with nab-paclitaxel, is indicated for the treatment of patients …
GEMTESA (vibegron) is an oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge urinary incontinence …
Filspari (sparsentan) is indicated for reducing urine protein levels (proteinuria) in adults with primary immunoglobulin A nephropathy (IgAN), who are …
ICOTYDE™ (icotrokinra) is the first and only targeted oral peptide indicated for the treatment of moderate-to-severe plaque psoriasis (PsO) in …
